To test the hypothesis that hyaluronan deposition contributes to COVID-19 pathology through interactions with CD44, we intranasally inoculated mice with a mouse-adapted strain of SARS-CoV-2 that has been previously characterized [42,43]. This evidence concerns the gene CD44 and COVID-19.